Skip to main content
NIH funding notice RFA-DA-15-006

Avenir Award Program for Genetics or Epigenetics of Substance Abuse (DP2)

Closed on June 17, 2015.

Posted
March 27, 2014
Close date
June 17, 2015
Activity codes
Not stated on the notice page
Institutes taking part
Not stated on the notice page

Read the notice on Grants.gov · NIH Guide page

The notices it replaced

Its page was not saved, so the notices it replaced are not known.

Who won it before

2 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $904,500 in first-year total cost, median $452,250.

Most frequent study sections

  1. Special Emphasis Panel[ZDA1 GXM-A (01)]2

Most frequent institutions

  1. UNIVERSITY OF ALABAMA AT BIRMINGHAM1
  2. UNIVERSITY OF CALIFORNIA-IRVINE1
Competing awards under RFA-DA-15-006 and the notices it replaced
FYProjectPIsInstitutionFirst-year costStudy section
2015Circulating miRNAs and Epigenetic Regulation in Nicotine Addiction1DP1DA039658-01FOWLER, CHRISTIE DUNIVERSITY OF CALIFORNIA-IRVINE, CA$463,500ZDA1
2015Epigenetic Control of Brain Reward Systems1DP1DA039650-01DAY, JEREMY JUNIVERSITY OF ALABAMA AT BIRMINGHAM, AL$441,000ZDA1

Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.

ScienceDex for faculty

Your academic CV and NIH biosketch

Make your CV in your school's format and your NIH biosketch from it, then download both as Word files.